title: [Conservative hormonal therapy for endometrial cancer].
authors.affiliation: Department of Obstetrics & Gynecology, Keio University School of Medicine.
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Susumu
authors.forename: Daisuke
authors.initials: D
authors.lastname: Aoki
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tamada
authors.forename: Koji
authors.initials: K
authors.lastname: Banno
authors.forename: Atsushi
authors.initials: A
authors.lastname: Suzuki
authors.forename: Nao
authors.initials: N
authors.lastname: Suzuki
authors.forename: Shiro
authors.initials: S
authors.lastname: Nozawa
mesh_terms: D000077713:17 alpha-Hydroxyprogesterone Caproate; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage* / Q000009:adverse effects; D019290:Megestrol Acetate; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D006908:Hydroxyprogesterones; D000077713:17 alpha-Hydroxyprogesterone Caproate; D017258:Medroxyprogesterone Acetate; D019290:Megestrol Acetate